A carregar...
Hypofractionated intensity modulated radiotherapy with temozolomide in newly diagnosed glioblastoma multiforme
We conducted a phase I study to determine (a) the maximum tolerated dose of peri-radiation therapy temozolomide (TMZ) and (b) the safety of a selected hypofractionated intensity modulated radiation therapy (HIMRT) regimen in glioblastoma multiforme (GBM) patients. Patients with histological diagnosi...
Na minha lista:
| Publicado no: | J Clin Neurosci |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4299456/ https://ncbi.nlm.nih.gov/pubmed/24380758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jocn.2013.09.005 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|